- Home
- ETD vs GHRS Comparison
ETD vs GHRS Comparison
Compare ETD & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETD
- GHRS
- Stock Information
- Founded
- ETD 1932
- GHRS 2018
- Country
- ETD United States
- GHRS Ireland
- Employees
- ETD N/A
- GHRS N/A
- Industry
- ETD Home Furnishings
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- ETD Consumer Discretionary
- GHRS Health Care
- Exchange
- ETD Nasdaq
- GHRS Nasdaq
- Market Cap
- ETD 763.7M
- GHRS 774.1M
- IPO Year
- ETD 1993
- GHRS 2021
- Fundamental
- Price
- ETD $27.62
- GHRS $13.04
- Analyst Decision
- ETD Hold
- GHRS Strong Buy
- Analyst Count
- ETD 2
- GHRS 8
- Target Price
- ETD $30.00
- GHRS $30.63
- AVG Volume (30 Days)
- ETD 266.9K
- GHRS 303.4K
- Earning Date
- ETD 10-29-2025
- GHRS 11-13-2025
- Dividend Yield
- ETD 6.56%
- GHRS N/A
- EPS Growth
- ETD N/A
- GHRS N/A
- EPS
- ETD 2.01
- GHRS N/A
- Revenue
- ETD $614,649,000.00
- GHRS N/A
- Revenue This Year
- ETD $1.12
- GHRS N/A
- Revenue Next Year
- ETD $3.79
- GHRS N/A
- P/E Ratio
- ETD $13.72
- GHRS N/A
- Revenue Growth
- ETD N/A
- GHRS N/A
- 52 Week Low
- ETD $24.55
- GHRS $6.00
- 52 Week High
- ETD $32.61
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- ETD 35.94
- GHRS 45.13
- Support Level
- ETD $28.43
- GHRS $12.67
- Resistance Level
- ETD $29.30
- GHRS $14.96
- Average True Range (ATR)
- ETD 0.55
- GHRS 0.75
- MACD
- ETD -0.15
- GHRS -0.07
- Stochastic Oscillator
- ETD 0.00
- GHRS 17.21
About ETD Ethan Allen Interiors Inc.
Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.